| 11/12/2026 8:29 AM | Biodesix (1439725) Issuer SCHULER JACK W (1021412) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/12/2026 8:29 AM | Biodesix (1439725) Subject SCHULER JACK W (1021412) Filed by | Form SCHEDULE 13D/A | |
| 11/05/2026 3:08 PM | Biodesix (1439725) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/13/2026 4:22 PM | Biodesix (1439725) Issuer SCHULER JACK W (1021412) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/12/2026 4:55 PM | Biodesix (1439725) Issuer SCHULER JACK W (1021412) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/05/2026 3:05 PM | Biodesix (1439725) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 06/18/2026 4:00 PM | Biodesix (1439725) Subject Soleus Capital Master Fund, L.P. (1812275) Filed by | Form SCHEDULE 13G | |
| 05/31/2026 11:15 PM | Biodesix (1439725) Filer | Form EFFECT | |
| 05/20/2026 3:18 PM | Biodesix (1439725) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/08/2026 4:00 PM | Biodesix (1439725) Subject Soleus Capital Master Fund, L.P. (1812275) Filed by | Form SCHEDULE 13G/A | |
| 05/04/2026 3:03 PM | Biodesix (1439725) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for BDSX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Biodesix and its competitors with MarketBeat's FREE daily newsletter.
|
| 05/04/2026 3:05 PM | Biodesix (1439725) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/28/2026 3:15 PM | Biodesix (1439725) Subject HIRSCHMAN ORIN (1131362) Filed by | Form SCHEDULE 13G | |
| 04/09/2026 3:24 PM | Biodesix (1439725) Filer | Form ARS | |
| 04/09/2026 3:14 PM | Biodesix (1439725) Filer | Form DEF 14A | |
| 04/09/2026 3:21 PM | Biodesix (1439725) Filer | Form DEFA14A | |
| 02/26/2026 3:06 PM | Biodesix (1439725) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/26/2026 3:02 PM | Biodesix (1439725) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/23/2026 7:22 PM | Biodesix (1439725) Subject Hutton Scott (1697361) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/23/2026 7:22 PM | Biodesix (1439725) Issuer Hutton Scott (1697361) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/23/2026 7:22 PM | Biodesix (1439725) Issuer Vazquez Chris (1980594) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/23/2026 7:22 PM | Biodesix (1439725) Issuer Cowie Robin Harper (1827690) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/23/2026 7:22 PM | Biodesix (1439725) Issuer O'Kane Kieran (1828131) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/23/2026 7:22 PM | Biodesix (1439725) Issuer Pestano Gary Anthony (1827711) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 5:03 PM | Biodesix (1439725) Issuer Pestano Gary Anthony (1827711) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 5:03 PM | Biodesix (1439725) Issuer Cowie Robin Harper (1827690) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 5:03 PM | Biodesix (1439725) Issuer Hutton Scott (1697361) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 5:03 PM | Biodesix (1439725) Issuer Vazquez Chris (1980594) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/11/2026 5:03 PM | Biodesix (1439725) Issuer O'Kane Kieran (1828131) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:14 PM | Biodesix (1439725) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 01/27/2026 1:28 PM | Biodesix (1439725) Subject SCHULER JACK W (1021412) Filed by | Form SCHEDULE 13D/A | |
| 01/27/2026 8:29 AM | Biodesix (1439725) Issuer SCHULER JACK W (1021412) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 12:59 PM | Biodesix (1439725) Subject Telemark Asset Management, LLC (1420816) Filed by | Form SCHEDULE 13G | |
| 01/26/2026 8:28 AM | Biodesix (1439725) Issuer SCHULER JACK W (1021412) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/23/2026 1:51 PM | Biodesix (1439725) Subject Telemark Asset Management, LLC (1420816) Filed by | Form SCHEDULE 13G/A | |
| 01/13/2026 3:31 PM | Biodesix (1439725) Subject Soleus Capital Master Fund, L.P. (1812275) Filed by | Form SCHEDULE 13G | |
| 01/12/2026 11:04 AM | Biodesix (1439725) Filer | Form 8-K/A | |
| 01/06/2026 3:25 PM | Biodesix (1439725) Issuer Kayyem Jon Faiz (1366268) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/06/2026 3:26 PM | Biodesix (1439725) Issuer Kennedy Lawrence T. Jr (1830773) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/06/2026 3:26 PM | Biodesix (1439725) Issuer MASSARANY HANY (1134554) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/06/2026 3:26 PM | Biodesix (1439725) Issuer PATIENCE JOHN (1021413) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Pentagon magnet restrictions take effect January 1, 2027 (Ad) A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It would build and operate a rare earth processing facility on an active military base, with the Army receiving first right to production.
The timing matters. New Pentagon restrictions on certain Chinese-origin rare earth magnets take effect January 1, 2027, while China controls more than 90% of global rare earth processing.
The company's mine-to-magnet platform spans feedstock agreements, processing facilities, metallization technology, and downstream manufacturing, with initial commercial output targeted for 2027. Read the full breakdown of the proposed Army rare earth agreement and the company behind it. |
| 01/06/2026 3:27 PM | Biodesix (1439725) Issuer Strobeck Matthew (1377832) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/06/2026 3:27 PM | Biodesix (1439725) Issuer Franchi Jean M. (1653053) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |